Skip to main content

Table 2 Operative details stratified by sarcopenia

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

 

All patients (n = 77)

n (%)

No sarcopenia (n = 47)

n (%)

Sarcopenia (n = 30)

n (%)

p-value

Elective surgery

 Yes

31 (40)

19 (40)

12 (40)

0.581a

 No

46 (60)

28 (60)

18 (60)

Indication for surgery

 Stage 2 surgery for IPPA

6 (8)

3 (6)

2 (7)

0.850

 Stricture

19 (24)

13 (28)

6 (20)

 Fistula

9 (12)

6 (13)

4 (13)

 Medically refractory disease

33 (43)

18 (38)

15 (50)

 Perforation

10 (13)

7 (15)

3 (10)

Type of surgery

 Open

18 (23)

7 (15)

11 (37)

0.153b

 Laparoscopic

52 (68)

35 (75)

17 (57)

 Laparoscopic-assisted

3 (4)

2 (4)

1 (3)

 Open → laparoscopic

4 (5)

3 (6)

1 (3)

Extent of surgery

 Completion proctectomy, ileal pouch anal anastomosis and end-ileostomy

5 (7)

3 (6)

2 (7)

0.557b

 Panproctocolectomy and end-ileostomy

6 (8)

3 (6)

3 (10)

 Sigmoid colectomy

6 (8)

5 (11)

1 (3)

 Ileocecectomy

14 (18)

9 (19)

5 (17)

 Anastomosis revision

1 (1)

1 (2)

0 (0)

 Right hemicolectomy

11 (14)

8 (17)

3 (10)

 Subtotal colectomy and end-ileostomy

27 (35)

15 (32)

12 (40)

 Left hemicolectomy and defunctioning loop ileostomy

1 (1)

1 (2)

0 (0)

 Completion proctectomy and end-ileostomy

3 (4)

1 (2)

2 (7)

 Ileorectal anastomosis

2 (3)

0 (0)

2 (7)

 Anterior resection and end-colostomy

1 (1)

1 (1)

0 (0)

  1. Elective surgery = planned hospital admission for surgery, non-elective surgery = non-planned surgical intervention. IPPA ileal pouch anal anastomosis
  2. a χ2 test, b Fischer’s exact test